PRAMOMOLECULAR
Description: PRAMOMOLECULAR develops innovative siRNA drugs to silence disease-causing proteins, targeting aggressive lung & pancreatic cancers.
Country: Germany
Based in: Berlin
Founded: 2021
Funding Stage: Seed
Tags: ['life sciences', 'drug development', 'onkology', 'gene silencing']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
